SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-030168
Filing Date
2023-06-27
Accepted
2023-06-27 16:53:19
Documents
12
Period of Report
2023-06-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K cycn-20230626.htm   iXBRL 8-K 63248
  Complete submission text file 0000950170-23-030168.txt   191872

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cycn-20230626_lab.xml EX-101.LAB 18527
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cycn-20230626.xsd EX-101.SCH 2477
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cycn-20230626_pre.xml EX-101.PRE 11562
6 EXTRACTED XBRL INSTANCE DOCUMENT cycn-20230626_htm.xml XML 4876
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Filer) CIK: 0001755237 (see all company filings)

IRS No.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38787 | Film No.: 231048131
SIC: 2834 Pharmaceutical Preparations